Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | GILD | MRNA | ||
| Company | Celgene Corp | Gilead Sciences Inc | Moderna Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 108.01 | 65.30 | 108.78 | ||
| High | 108.59 | 66.91 | 112.33 | ||
| Low | 107.27 | 65.20 | 108.72 | ||
| Last | 108.24 | 65.94 | 111.62 | ||
| Change | +0.11 | +0.52 | +3.65 | ||
| % Change | +0.10% | +0.79% | +3.38% | ||
| Volume | 191,230,496 | 7,838,800 | 2,610,700 | ||
| 20-Day Average Volume | 16,188,930 | 7,264,530 | 3,037,220 | ||
| Previous Close | 108.13 | 65.42 | 107.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 67.95 | 105.37 | ||
| 20-Day Raw Stochastic | 63.25% | 15.94% | 77.40% | ||
| 20-Day Relative Strength | 64.69% | 32.30% | 58.62% | ||
| Weighted Alpha | +46.30 | -20.72 | -6.87 | ||
| Today's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -1.51% since 04/22/24 | +6.85% since 04/22/24 | ||
| Low | 107.27 on 11/20/19 | 64.63 on 04/26/24 | 103.48 on 04/23/24 | ||
| High | 110.53 on 11/14/19 | 67.90 on 04/25/24 | 112.33 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | -9.98% since 03/28/24 | +4.75% since 03/28/24 | ||
| Low | 102.40 on 10/21/19 | 64.63 on 04/26/24 | 97.00 on 04/03/24 | ||
| High | 110.70 on 11/13/19 | 73.22 on 04/01/24 | 115.89 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -16.61% since 01/29/24 | +6.47% since 01/29/24 | ||
| Low | 93.41 on 08/23/19 | 64.63 on 04/26/24 | 84.06 on 02/13/24 | ||
| High | 110.70 on 11/13/19 | 79.03 on 01/31/24 | 115.89 on 04/09/24 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | -13.94% since 10/27/23 | +55.22% since 10/27/23 | ||
| Low | 89.08 on 07/23/19 | 64.63 on 04/26/24 | 62.55 on 11/02/23 | ||
| High | 110.70 on 11/13/19 | 87.86 on 01/19/24 | 115.97 on 01/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 81,452,936 | 41,339,556 | ||
| Shares Outstanding, K | 711,714 | 1,245,077 | 382,880 | ||
| Annual Sales | 15,281,000,000 | 27,116,000,000 | 6,848,000,000 | ||
| Annual Net Income | 4,046,000,000 | 5,665,000,000 | -4,714,000,000 | ||
| Last Quarter Sales | 4,520,000,000 | 7,114,000,000 | 2,811,000,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 1,429,000,000 | 217,000,000 | ||
| 60-Month Beta | 1.41 | 0.19 | 1.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | -1.32 on 04/25/24 | 0.55 on 02/22/24 | ||
| Latest Earnings Date | 10/31/19 | 04/25/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | 0.770 on 03/14/24 | N/A | ||
| Next Ex-Dividends Date | N/A | 06/14/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 16.20 | 0.00 | ||